Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Circ Genom Precis Med. 2022 Sep 22;15(5):e003675. doi: 10.1161/CIRCGEN.121.003675

Table 6.

Phenotypes in Carriers of Pathogenic/Likely Pathogenic Variants Associated with Long QT Syndrome

Carriers (N=23) Noncarriers (N=115) P value
Demographics
Age, years 69.2 ± 11.1 69.2 ± 10.9 NA
Female 8 (35%) 40 (35%)
Genetic ancestry
 European 18 (78%) 90 (78%)
 African 5 (22%) 25 (22%)
Long QT syndrome risk score electrocardiogram categories
 Individuals with electrocardiogram 18 (78%) 86 (75%) 1
  QTc ≥480 ms 7 (39%) 9 (10%) 0.01 *
  QTc = 460–479 ms 2 (11%) 12 (14%)
  QTc = 450–459 ms in males 1 (6%) 5 (6%)
  QTc <450 ms in males or <460 ms in females 8 (44%) 60 (70%)
Long QT syndrome risk score electrocardiogram and clinical criteria
 Syncope 2 (9%) 18 (16%) 0.5
 Syncope with stress 0 0 NA
 Congenital deafness 0 0 NA
 Torsades de pointes 0 0 NA
Long QT syndrome risk score family history criteria
 Family history of long QT syndrome 1 (4%) 0 0.2
 Family history of unexplained sudden cardiac death 0 0 NA
Long QT syndrome risk score diagnostic probability
 Low probability 14 (61%) 93 (81%) 0.04 *
 Intermediate probability 9 (39%) 21 (18%)
 High probability 0 1 (1%)
Other findings
 QTc, ms 465 ± 39 439 ± 34 0.005
 QTc ≥500 ms in repeated electrocardiograms 1 (4%) 0 0.2
 Atrial fibrillation/flutter 7 (30%) 44 (38%) 0.6
 Nonsustained/sustained ventricular tachycardia 2 (9%) 28 (24%) 0.2
 Implantable cardioverter-defibrillator 2 (9%) 14 (12%) 1
 Obstructive coronary artery disease 10 (43%) 76 (66%) 0.06

Continuous measures are described as mean ± standard deviation and are compared using two-sided Student’s t-test. Categorical variables are described as N (%); p values are calculated using Fisher’s exact test for dichotomous variables and Wilcoxon rank-sum test for ordinal variables (indicated by *). P values in bold indicate p <0.05. NA, not applicable; QTc, QT interval corrected for heart rate using Bazett’s formula.